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 ABSTRACT 
Introduction. It is known that patients with ischemic heart diseases have 
endothelial dysfunction, but there is lack of research about microcirculation 
in these patients with diffuse liver diseases, especially diagnosed with digital 
capillaroscopy. Aim. To investigate hemodynamic disorders and 
microcirculation in patients with chronic ischemic heart disease depending 
on the presence of diffuse liver diseases and its severity with the digital 
capillaroscopy. Materials and methods. Our prospective study included 187 
patients according to the criteria of inclusion. The data of echocardiography 
and digital capillaroscopy were analysed. Results. In our research in patients 
with ejection fraction less than 40% there was revealed thickening of the 
wall of the left ventricle, low blood supply in arterial and venous parts of 
capillaries. Patients with ejection fraction less than 40% and progressive 
diffuse liver diseases had advanced thickening of the wall of the left 
ventricle. Patients with liver cirrhosis had more adverse changes in 
hemodynamics. Patients with ischemic heart disease and diffuse liver disease 
had the worst capillary blood supply. Patients with ejection fraction less than 
40% and diffuse liver diseases had structural changes of capillaries such as 
bi-, trifurcation and bushy forms. Conclusions. So, diffuse liver diseases, 
especially severe, cause endothelial dysfunction in patients with ischemic 
heart diseases. Digital capillaroscopy is a noninvasive method for 
microcirculation diagnosis and patients’ monitoring. 
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Introduction. Capillaroscopy is a noninvasive method of microcirculation (MC) investigation 
[1-3] and is widely used in patients with ischemic heart disease (IHD), but there are only few scientific 
works about MC in patients with IHD and concomitant diffuse liver diseases (DLD).  
Aim. To investigate hemodynamic dysfunction and microcirculation in patients with chronic 
IHD depending on concomitant DLD with digital capillaroscopy.  
Materials and methods. We conducted open prospective investigation in the Medical center 
‘Doctor Vera’ and diagnostic department of Medbud Clinic from 2009 till 2019. Patients were selected 
MEDICINE 
WORLD SCIENCE                                                                                                                          ISSN 2413-1032 
 
                                                                     № 11(51), Vol.2, November 2019 5 
 
in the study according to the criteria of inclusion: presence of IHD and DLD. There was one more 
group with 30 healthy volunteers. The investigation was conducted according to the standards of Good 
Clinical Practice, Ukrainian medical law and all patients signed informed agreement. 187 patients 
were included in the study – 34 women and 154 men from 18 to 85 years old (average age was 
46,1±17,4). There were three groups in our study. 
The first group included 55 patients with chronic IHD and with chronic heart insufficiency (CHI) I-
II B stages, І–ІV functional classes, average age 61,5±12,8 and there were 16 women (29%) with ejection 
fraction of the left ventricle (EFlv) 44,2±8,6% (Table 1). The average duration of IHD was 8,2±5,7 years. 
The first group was divided into subgroups A and B depending on the presence (1B) or absence (1A) of the 
DLD. The subgroup 1B included the following DLD: 5 (20%) patients with chronic toxic hepatitis (CTH), 
14 (56%) – nonalcoholic steatohepatitis (NASH), 5 (20%) – chronic viral hepatitis (CVH) B and C (CVHB, 
CVHC), 3 (12%) – liver cirrhosis (LC) A-B classes according to Child-Pugh, 3 (12%) – cryptogenic 
hepatitis. More than one third of the patients with IHD had myocardial infarction. All the patients had 
concomitant hypertensive disease. Patients with NASH had insulin-independing type 2diabetes mellitus. 
Table 1. Data of the patients with IHD  
№ 
п/п 
Data 1 group (n=55) 
In general 1А n=30 1Б n=25 
1 Age (years) 61,5±12,8 60,2±11,0 58,8±12,4 
2 % men 71% (39) 63,3% (19) 80% (20) 
3 Hypertensive disease 100% (55) 100% (30)  100% (25) 
4 Ventricular extrasystoles 11% (6) 10% (3) 12% (3) 
6 Type 2 diabetes mellitus 22%(12) 30%(10)* 8% (2) 
6 Myocardial infarction in anamnesis of 
disease 
42% (23)  50% (15) 32% (8) 
7 Acute disturbances of cerebral blood 
circulation/Transient ischemic attack 
in anamnesis of disease 
3,6% (4) 6,6%(2) 8% (2) 
Abbreviations: *р<0,05 comparing within groups. Continuous variables were expressed as 
mean±SD. Categorial variables were expressed as percentage. 
The second group included 102 patients with DLD, average age was 37,3±15,2 years: 12 
patients with LC, average age was 45,1±9,2 years; 43 patients with CVH: 6 women, average age was 
31,8±8,9 years, 12 patients with CVHB, 24 patients with CVHC, 4 patients with CVHB+С, 2 patients 
with viral hepatitis Epstein-Barr, 1 patient with CVB TTV; 21 patients with chronic toxic hepatitis of 
mixed etiology, especially alcoholic, average age 42,7±12,6 years; 26 patients with NASH, average 
age 40,8±10,0 years. We also analysed the data of the patients in the second group according to the 
stages of liver diseases: subgroup A – 48 patients with minimal cytolytic syndrome and cholestasis 
(elevation of alaninaminotransferase (ALT) less than in 5 times; bilirubin was less than 100 mcmol/l); 
subgroup B – 42 patients with moderate syndrome of cytolysis and cholestasis (elevation of ALT in 5-
10 times, bilirubin from 100 to 200 mcmol/l); subgroup В – 12 patients with LC.  
The third group included 30 healthy volunteers (8 women (25,7%) and 22 men (74,3%)), 
average age 33,5±8,4 years. 
Transthoracic echocardiography (echo) was conducted on the device HDI 11XE Philips 
according to the general methodology [1] with measurement in 2D-regime of wall thickness of the 
right ventricle (Trv), posterior wall of the LV (Tlv), intraventricular septum (Tivs), short-axis size of 
the left atrium (LA), terminal diastolic volume (TDV) of LV by Simpson, its EF and also short-axis 
size of the RV in basal chamber (Drv(k)), diameter of vena cava inferior (VCI). Diastolic filling of the 
LV was evaluated according to the ratio of transmitral flow velocity in the period of rapid filling and 
in systolic phase of the LA (E/A), time of decreasing of early diastolic filling velocity (DT) and 
duration of the period of left ventricular isometric relaxation (IVRT). Systolic pressure of the 
pulmonary artery (SPpa) was evaluated by the speed of tricuspid regurgitation flow.  
Digital capillaroscopy (DC) was conducted on the device ООО «Micropotic» Kyiv with the 
programme AngioPro. The following data of DC were measured: diameter of the arterial part of the 
capillary (DAC), diameter of the venous part of the capillary (DVC), length of the arterial part (LAC) 
and venous part (LVC) of the capillary, blood flow velocity of the arterial part (FVAC) and venous 
part of the capillary (FVVC). 
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Statistical analyses was made with Statistica for Windows 7.0 (Statsoft, USA). Distribution of 
the values wasexpressed as median, mean and Shapiro-Wilk criterion. Comparing groups was held 
with Vilkokson-Mann-Witney criterion. Reliability of nonparametric data discrepancies in groups 
(including follow-up period) was made with Chi-square criterion. Correlation analyses was made with 
Pearson’s correlation croterion. The discrepancies were statistically significant at р<0,05. 
Results and discussion. According to the recommendations of the Ukrainian association of 
cardiologists of diagnosis, treatment and prevention of CHI in adults (2017) we divided our patients 
into two groups: group 1 with normal EF of the LV systolic function (EFlv>40%) and group 2 with 
reduced EF (EFlv<40%). For additional evaluation of the stage of diastolic dysfunction of LV we 
created subgroups with E/A more and less than 1 in every group. We evaluated the fact that Е/А>1,0 
at EFlv<40%  was related to the pseudonormal/restricrive type of transmitral flow and in case of 
EFlv>40% Е/А>1,0 better diastolic filling of LV was performed comparing the patients with Е/А<1,0 
(diastolic dysfunction of the LV by relaxation disorder type). Part of the patients with concomitant 
DLD among the patients with EFlv> 40% was 41% and among the patients with EFlv<40% - 50%.  
The data of intracardiac hemodynamics of the both groups confirmed the dilatation of the 
ventricles and LA, thickening of the ventricles’ walls, increasing of the pressure in the pulmonary 
artery, size of the VCI (Table 2). Patients with EFlv<40% had elevated data of TDV, Tivs, Tlv, SPpa, 
VCI comparing to the patients with EFlv>40%. Patients with EFlv>40% and Е/А>1,0 had less 
thickening of the walls of LV and this provd the dependence of LV rigidity from the thickness of its 
walls. Patients with EFlv<40% and Е/А>1,0 had higher data of TDV and LA and lower data of IVRT і 
DT comparing to the subgroup with EFlv<40% and Е/А<1,0 which proved the increased load of the 
ventricles and LA at pseudonormal and restrictive types of diastolic dysfunction.  
Table 2. Data of echo in patients with IHD depending on the condition of systolic and diastolic 
functions of LV  
Data of 
EchoKG M±SD 
EF>40% 
(n=14) 
EF>40% 
Е/А>1,0 
(n=9) 
EF>40% 
Е/А<1,0 
(n=5) 
EF<40% 
(n=16) 
EF<40% 
Е/А>1,0 
(n=10) 
EF<40% 
Е/А<1,0 
(n=6) 
Healthy 
volunteers 
(n=30) 
Тrv, cm 0,40± 
0,14* 
0,40± 
0,11* 
0,40± 
0,15* 
0,44± 
0,13* 
0,45± 
0,14* 
0,44± 
0,13* 
0,32±0,11 
LA, cm 4,37±0,62* 4,45± 
0,55* 
4,37± 
0,69* 
4,47± 
0,50* 
4,66± 
0,68* 
4,38± 
0,36* 
3,62±0,09 
Тivs, cm 1,01± 
0,09* 
0,95± 
0,06*† 
1,05± 
0,09* 
1,05± 
0,11* 
1,04± 
0,10* 
1,06± 
0,12* 
0,88±0,07 
Тlv, cm 1,01±0,11 0,98± 
0,07*† 
1,03± 
0,09* 
1,05± 
0,12* 
1,05± 
0,13* 
1,05± 
0,12* 
0,88±0,06 
EFlv,% 51,7± 
5,2*§ 
50,3± 
5,4* 
51,4± 
6,3* 
37,6± 
5,1* 
37,8± 
4,12* 
37,5± 
5,6* 
67,4±2,5 
TDV, ml 165±25*§ 161±31* 163±33* 185±43* 211±46*† 172±32* 121±24 
Е/Аlv 0,89± 
0,33* 
1,29± 
0,29† 
0,72± 
0,17* 
0,96± 
0,56 
1,49± 
0,67† 
0,72± 
0,15* 
1,34±0,12 
IVRT,ms 95±15* 86±15† 99±13* 93±13* 86±11† 96±12* 81,5±2,1 
DT, ms 196±35* 181±29 199±33* 190±41* 155±25*† 209±35* 179±14 
SPpa,mm Hg 30,0± 4,1*§ 30,7± 
6,0* 
29,8± 
3,3* 
34,5± 
7,7* 
37,3± 
10,5* 
33,0± 
5,3* 
26,3±0,6 
DiameterRV(k), 
cm 
2,51± 
0,45* 
2,60± 
0,70* 
2,48± 
0,31* 
2,58± 
0,36* 
2,69± 
0,55* 
2,53± 
0,21* 
2,12±0,10 
VCI, cm 2,07±0,21* 2,07± 
0,23* 
2,07± 
0,21* 
2,19± 
0,36* 
2,53± 
0,46*† 
2,13± 
0,22* 
1,80±0,30 
Abbreviations: *р<0,05 comparing to control group.  
§р<0,05 comparing groups with EFlv. 
†р<0,05 comparing with patients with Е/А<1,0 at the same EFlv. 
We have analysed the data of DC in patients with IHD (Table 3) and have found decrease of 
DAC, DVC, FVAC and FVVC which proved the reduction of capillary flow as a result of mio- and 
neurotone elevation, peripheral resistance venous outflow dysfunction due to CHI. In patients with 
EFlv<40% decreased data of FVAC and FVVC demonstrated the reduction of blood supply of 
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microcirculation due to [4] reduced cardiac output and blood volume in capillaries and elevation of 
tone of vessels of middle and small calibres as a result of activated sympathetic-adrenal system (SAS), 
renin-angiotensin-aldosterone system and hyperproduction of vasoconstrictors [5].  
Table 3. Data of DC in patients with IHD depending on the condition of systolic and diastolic 
functions. 
Data of DC 
M±SD 
EF>40% 
Е/А>1,0 
(n=9) 
EF>40% 
Е/А<1,0  
(n=5)  
EF<40% 
Е/А>1,0  
(n=10) 
EF<40% 
Е/А<1,0 
(n=6) 
Healthy 
volunteers 
(n=30) 
DAC, mcm 11,8±4,1† 8,3±2,4* 7,1±3,5*§ 9,3±2,6* 12,5±2,3 
DVC, mcm 14,2±5,3 11,4±5,1*  13,3±4,7* 14,5±3,1 15,1±3,9 
LAC, mcm 228(182-373) 304(183-406)* 212(275-510)* 312 (190-475)* 402(207-611) 
LVC, mcm 237(190-388) 315 (202-423) 270 (201-603)* 320 (185-405)* 455 (216-701) 
FVAC, mcm/s 408(181-650)* 370(227-584)* 340 (130-509)* 315 (122-439)* 612 (349-950) 
FVVC, mcm/с 381(145-473)* 290(121-405)* 264 (120-343)* 270 (219-431)* 560 (350-890) 
Abbreviations: continuous variables were expressed as median (interquartile range). 
u – Vilkokson-Mann-Witney criterion.  
*u<0,05 comparing to the healthy volunteers.  
§u<0,05 comparing groups with different data of EFlv. 
†u<0,05 comparing with patients with Е/А<1,0 at the similar EFlv. 
The results of echo investigation in the groups are presented in Table 4. All the patients with 
IHD had enlargement of cavity and thickening of the wall of LV with its contraction dysfunction and 
diastolic filling, enlargement of cavity and thickening of the wall of RV, enlargement of the LA and 
VCI, elevation of pressure in the PA. Patients with IHD had higher degree of dysfunction of structural 
and functional changes of different heart chambers comparing to the patients with DLD. Patients with 
IHD and concomitant DLD had higher data of Trv, EFlv and lower data of TDVlv.  
Table 4. Distribution of echo data  
Data of echo 
(M±SD)  
IHD 
N=30 
IHD + DLD 
n=25 
DLD 
n=102   
Healthy volunteers 
n=30 
Trv, cm 0,38±0,02   0,48±0,12*^  0,43±0,01*^ 0,32±0,11 
LA, cm 4,45±0,09* 4,39±0,07* 3,90±0,04^# 3,62±0,09 
Tivs, cm 1,02±0,03* 1,05±0,01* 0,95±0,01*^# 0,88±0,07 
Tlv, cm 1,02±0,02* 1,05±0,01*^ 0,96±0,01*^# 0,88±0,06 
EFlv, % 44,1±8,6*  46,1±8,9* 64,5±0,4*^# 67,4±2,5 
TDVlv, ml 176±33*  170±44* 128±12^# 121±24 
Е/Аlv  0,82±0,41* 0,98±0,48* 1,06±0,03*^ 1,34±0,12 
IVRT, ms 94,5±16,2*  94,4±10,0* 85,1±1,3^# 81,5±2,1 
DT, ms 199±25* 186±43 181±13^ 179±14 
SPpa, mmHg 32,1±0,8* 32,0±1,0* 29,6±0,4*^ 26,3±0,6 
DiameterRV(k), cm 2,49±0,06* 2,59±0,05* 2,53±0,04*  2,12±0,10 
VCI, cm 2,06±0,03 2,21±0,05* 2,23±0,21*^ 1,80±0,30 
Abbreviations: Continuous variables were expressed as mean±SD. 
*р<0,05 comparing to the healthy volunteers. 
^р<0,05 comparing to the patients with IHD. 
#р<0,05 comparing to the patients with IHD and DLD.  
We analyzed the data of echo of our patients with IHD and concomitant DLD according to the 
similar data of EFlv because it was difficult to evaluate classical clinical criteria of heart insufficiency 
such as stuffiness, tachycardia, hepatomegaly, oedema, ascites, hydrothorax etc. (Table 5). Patients 
with IHD and EFlv>40% and with DLD had thickening of the walls of the ventricles at analyzing the 
data of echo. Patients with EFlv<40% and DLD had significantly advanced thickness of the wall, short 
size of the RV and diameter of VCI. The main cause of the remodeling processes of RV and LV could 
be changes of metabolism of vasoactive factors and liver hemodynamic dysfunction.  
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Table 5. Data of echo in patients with IHD and DLD to the similar data of EFlv  
Data of echo  IHD EFlv>40%  IHD EFlv<40% Healthy 
volunteers with DLD without DLD with DLD without DLD 
M±SD N=13 n=14 n=12 n=16 n=30 
Trv, cm 0,45±0,13*† 0,37±0,13 0,48±0,13*† 0,40±0,12* 0,32±0,11 
LA, cm 4,36±0,44* 4,42±0,78* 4,47±0,53* 4,47±0,48* 3,62±0,09 
Tivs, cm 1,05±0,11*† 1,00±0,08* 1,06±0,11* 1,03±0,11* 0,88±0,07 
Tlv, cm 1,05±0,11*† 0,99±0,07* 1,07±0,12* 1,04±0,12* 0,88±0,06 
EFlv, % 52,6±8,2* 50,2±3,3* 39,9±3,5*† 35,0±5,4* 67,4±2,5 
TDVlv, ml 163±37* 165±29* 177±50* 194±33* 121±24 
Е/Аlv  0,90±0,27* 0,86±0,37* 1,05±0,62* 0,87±0,48* 1,34±0,12 
IVRT, ms 93±10* 97±17* 94±9* 91±15* 81,5±2,1 
DT, ms 189±36* 197±31* 184±49 198±29* 179±14 
SPpa, mmHg 29,8±3,4* 30,2±4,6* 34,0±7,9* 35,0±7,5* 26,3±0,6 
DiameterRV(k), cm 2,55±0,25* 2,48±0,55* 2,67±0,44*† 2,49±0,22* 2,12±0,10 
VCI, cm 2,12±0,12* 2,04±0,22* 2,27±0,44*† 2,10±0,23* 1,80±0,30 
Abbreviations: Continuous variables were expressed as mean±SD. 
*р<0,05 comparing to the healthy volunteers.  
†р<0,05 comparing to the patients with IHD and without DLD at the similar data of EFlv. 
We analysed the data of echo in patients with DLD depending on the liver damage for 
understanding the influence of concomitant DLD on the condition of hemodynamics in patients with 
IHD (Table 6). The worst prognostic data were revealed in patients with LC. 
Table 6. Data of echo in patients with DLD depending on the etiology  
Data of echo Normal  
n=30 
NASH 
n=26 
CTH 
N=21 
CVH 
n=43 
LC 
n=12 
Trv, cm 0,32±0,11 0,41±0,11^  0,44±0,40^  0,40±0,09*^ 0,57±0,11* 
LA, cm 3,62±0,09 4,10r0,37* 3,90r0,36*^ 3,73r0,33*^  4,24±0,51* 
Tivs, cm 0,88±0,07 0,99r0,14* 0,95r0,10^ 0,92r0,08^  1,02±0,11* 
Tlv, cm 0,88±0,06 0,98r0,11 0,97r0,10*^ 0,92r0,08*^ 1,02±0,14* 
EFlv, % 67,4±2,5 64,4r4,6  64,9r2,5  66,0r2,9^ 63,3±4,8* 
TDVlv, ml 121±24 132r16* 126r20* 123r20^ 136±21 
Е/Аlv  1,34±0,12 0,96r0,21* 1,03r0,24* 1,18r0,30*^ 0,86±0,22* 
IVRT, ms 81,5±2,1 89,0r10,0  87,1r12,0  80,6r12,1 89,8±14,0 
DT, ms 179±14 173r31*^ 178r37  181r30 197±36 
SPpa, mmHg 26,3±0,6 27,3r2,7^ 29,5r2,5* 29,5r4,8* 33,9±4,5* 
DiameterRV(k), cm 2,12±0,10 2,50r0,26  2,50r0,20*  2,49r0,33*^ 2,91±0,43* 
VCI, cm 1,80±0,30 2,14r0,33* 2,20r0,18* 2,20r0,22* 2,55±0,21* 
Abbreviations: Continuous variables were expressed as mean±SD. 
*p<0.05, comparing to the controls.  
^р<0,05 comparing to the group with LC.  
In our study the most significant changes of hemodynamics were revealed in patients with LC 
and included the enlargement of the walls and cavity of the ventricles, dysfunction of contraction and 
filling of the left ventricle, dilatation of the left atrium, pulmonary hypertension (Table 7). 
Table 7. Data of echo with DLD to the damage degree  
Data of echo 
M±SD 
LC 
n=12  
DLD with moderate 
degree of damage  
n=38  
DLD with minimal 
degree of damage  
n=52 
Healthy 
volunteers 
n=30 
1 2 3 4 5 
Trv, cm 0,57±0,11* 0,40±0,10^ 0,41±0,12^ 0,32±0,11 
LA, cm 4,24±0,51* 3,69±0,33^ 3,96±0,56^ 3,62±0,09 
Tivs, cm 1,02±0,11* 0,91±0,08^ 0,96±0,11* 0,88±0,07 
Tlv, cm 1,02±0,14* 0,91±0,07^ 0,97±0,10* 0,88±0,06 
EFlv, % 63,3±4,8* 66,1±3,1* 64,8±3,9* 67,4±2,5 
TDVlv, ml 136±21 122±21^ 129±18^  121±24 
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Continuation of table 7. 
1 2 3 4 5 
Е/Аlv  0,86±0,22* 1,17±0,52^ 1,03±0,27*^ 1,34±0,12 
IVRT, ms 89,8±14,0 81,6±13,8 86,3±10,9  81,5±2,1 
DT, ms 197±36 184±32 176±30^  179±14 
SPpa, mmHg 33,9±4,5* 30,5±3,2*^ 28,0±2,9*^ 26,3±0,6 
DiameterRV(k), cm 2,91±0,43* 2,58±0,37*^# 2,41±0,21*^ 2,12±0,10 
VCI, cm 2,55±0,21* 2,19±0,22*^ 2,18±0,25*^ 1,80±0,30 
Abbreviations: Continuous variables were expressed as mean±SD. 
*р<0,05 comparing to the  healthy. 
^ р<0,05 comparing to the group with LC.  
# р <0,05 comparing to the patients with minimal damage.  
According to the results of DC (Table 8) in patients with IHD and without DLD there was 
reduction of LAC, LVC, FVAC and FVVC due to the elevation of SAS and local peripheral resistance 
[6]. Patients with DLD had decreased FVAC and FVVC as the result of the remodeling of capillary flow. 
Patients with IHD and DLD had higher stage of capillary flow disorder due to the production of 
inflammatory cytokines and disturbances of its utilization by the liver. We also revealed in our study that 
there was different pathomorphology of capillary flow changes. Patients with IHD and DLD had long 
forms because of elevation of peripheral resistanse, spasm of precapillary sphincters and activation of 
SAS. Patients with DLD had more tortuous and distorted short capillary loops which proved the 
dysfunction of outflow. Patients with IHD had lower DAC as the result of elevation of local peripheral 
resistanse and reduction of microcirculation [7]. 
Table 8. Data of DC in patients with IHD and DLD  
Data of DC Groups 
IHD 
n=30 
IHD + DLD 
n=25 
DLD 
N=102 
Healthy volunteers 
n=30 
DAC, mcm 
М±SD 
11,2±5,4^ 14,1±3,1* 13,7±4,3# 12,5±2,3 
DVC, mcm 
М±SD 
13,5±4,7^ 16,8±5,2* 14,6±6,5 15,1±3,9 
LAC, mcm 317 (190-475)*^ 353 (210-505)* 284 (183-526)*^ 402 (207-611) 
LVC, mcm 321 (185-405)*^ 382 (279-483)* 292 (197-404)* 455 (216-701) 
FVAC, mcm/s 380 (122-476)* 326 (202-605)*# 365 (122-586)* 612 (349-950) 
FVVC, mcm/с 270 (219-431)* 310(210-658)*# 350 (219-567)* 560 (350-890) 
Abbreviations: continuous variables were expressed as median (interquartile range). 
*u<0,05 comparing to the control with Vilkokson-Mann-Witney criterion.  
^ u <0,05 comparing to the subgroup IHD+DLD. 
# u <0,05 comparing to the subgroup IHD.  
According to the results of our analyses (Table 9) patients with EF>40%, IHD and DLD had 
accelerated data of DAC, lower data of FVAC as the result of decreasing of arteriole tone and 
dilatation of precapillary sphincters. It could be caused by the changes of liver function with elevation 
of vasodilatators such as nitric oxide, prostacyclin and glucagon and decreased sensitivity of arteriole 
to the catecholamines and angiotensin-II etc. [7]. Patients with EFlv<40% with DLD had lower data of 
FVAC due to the decreased tone (paresis) of precapillary sphincters and decreased FVVC as a result 
of stasis (disturbed venous outflow). It could be caused by hyperproduction of tumornecrotic-factor-D 
and interleukines-1,6,8, metabolism disturbances of vasoconstrictors by the damaged liver. That is 
why patients have structural changes of capillaries such as bi-, trifurcation and bushy forms. Patients 
with IHD and stages of EFlv decrease had clear signs of reduction blood supply due to the 
disturbances of central hemodynamics, atherosclerosis of vessels and elevation of its tone. In patients 
with IHD and DLD we didn’t find the decreasing of DC data according to the lowering of EFlv. 
Patients with IHD and DLD with EFlv>40% had tendency to the decrease of vessels’ tone and 
microcirculation compared to the patients without DLD due to the oedema of Disse’s space, reduced 
numbers of star-shaped cells, metabolism disorder of extracellular matrix-proteins, chemokines, 
cytokines, liver fibrosis.  
WORLD SCIENCE                                                                                                                          ISSN 2413-1032 
 
10 № 11(51), Vol.2, November 2019                                                                        
 
Table 9. Data of DC in patients with IHD depending on the presence of concomitant DLD and EFlv 
Data of DC IHD EF>40% IHD EF<40% Control 
With DLD without DLD with DLD without DLD 
Mediana  N=13 n=14 n=12 n=16 n=30 
DAC, mcm 
M±SD 
14,7±2,7* 11,2±3,9*† 13,1±6,8 10,1±2,3* 12,5±2,3 
DVC, mcm 
M±SD 
17,3±6,0* 14,1±5,0 15,2±4,5* 12,9±4,7 15,1±3,9 
LAC, mcm 353 (240-505)* 228(201-378) 327 (210-475)* 301 (247-479)* 402 (207-611) 
LVC, mcm 382(279-550)* 237(190-388) 364 (279-502)* 324 (238-482)* 455 (216-701) 
FVAC, mcm/s 341 (282-605)* 408(181-650)* 297 (202-572)* 380 (211-495)*† 612 (349-950) 
FVVC, mcm/с 335(307-658)* 381(145-473)* 258 (210-591)* 302 (185-410)* 560 (350-890) 
Abbreviations: continuous variables were expressed as median (interquartile range). 
*u <0,05 comparing to the control with Vilkokson-Mann-Witney criterion. 
†u <0,05 comparing to the oaients with IHD and without DLD similar to the EFlv. 
According to the results of DC data in patients with DLD of different etiology (Table 10) the 
worst stage of hemodynamic disorder was revealed in patients with LC. In groups with CTH and 
NASH the DAC was the biggest due to the disorder of liver utilization of glucagon, prostaglandins, 
adenosine, biliary acids and etc.  
Table 10. Data of DC in patients with DLD of different etiology  
Data of DC DLD lC 
n=14  
Viral hepatitis 
n=43 
Chronic toxic 
hepatitis  
n=21  
NASH 
n=26 
Control 
group  
n=30 
DAC, mcm 
M±SD 
10,7±4,1*#† 13,0±6,1^ 14,4±5,2*^ 15,1±4,3*^ 12,5±2,3 
DVC, mcm 
M±SD 
12,8±5,5*#† 14,3±5,2^ 15,7±4,9^ 16,2±4,1*^ 15,1±3,9 
LAC, mcm 265 (183-471)*# 374 (201-584)  ^ 194(189-307)*^ 284 (183-526)* 402 (207-611) 
LVC, mcm 278 (180-364)* 380 (217-420)^ 216(197-328)*^ 292 (197-404)* 455 (216-701) 
FVAC,mcm/s 165 (122-386)* 539 (470-578)^ 341 (145-450)*^ 403(218-517)*^† 612 (349-950) 
FVVC, mcm/с 158 (219-277)* 528 (306-560)^ 332 (228-439)*^ 377(219-503)*^# 560 (350-890) 
Abbreviations: continuous variables were expressed as median (interquartile range). 
*u <0,05 comparing to the control with Vilkokson-Mann-Witney criterion. 
^ u <0,05 comparing to the patients with LC. 
† u <0,05 comparing to the patients with viral hepatitis.  
# u <0,05 comparing to the patients with chronic toxic hepatitis. 
In our study we revealed (Table 11) that with DLD of minimal liver damage had slighter changes of 
DAC, DVC, FVAC and FVVC compared to the patients with LC due to the decreased tone of precapillary 
sphincters and elevation of capillary blood supply. Patients with moderate syndrome of cytolysis/cholestasis 
had slighter disorder of venous outflow, decreasing of peripheral resistance of precapillaries according to the 
DAC and DVC data and capillary microcirculation according to the FVAC and FVVC compared to the 
patients with LC due to the hyperproduction of the proinflammatory cytokines. Elevation of liver damage 
was characterized by phases changes of DAC, FVVC and FVAC due to the hyperactivity of L-arginine-NO 
and depletion of reticulo-endothelial system of liver in heavy hepatitis and LC [8-10]. The highest stage of 
liver blood supply dysfunction was in patients with LC due to the hyperproduction and/or disorder of 
vasoconstrictor utilization and structural and functional changes in the liver [11-14]. 
Table 11. Data of DC in patients with DLD to the stages of liver damage  
Data of DC  DLD LC 
n=12 
DLD of moderate 
liver damage  
n=38 
DLD of minimal liver 
damage  
n=52 
Control group  
n=30  
DAC, mcm 
M±SD 
10,7±4,1* 15,6±4,3*^ 14,8±4,3# 12,5±2,3 
DVC, mcm 
M±SD 
12,8±5,5* 16,1±3,1^ 15,0±3,9# 15,1±3,9 
LAC, mcm 265 (183-471)* 302(198-417)* 285 (185-391)* 402 (207-611) 
LVC, mcm 278 (180-364)* 310 (217-412)* 288 (189-405)* 455 (216-701) 
FVAC, mcm/s 165 (122-386)* 518 (122-586)* 412 (218-517)*^ 612 (349-950) 
FVVC, mcm/с 158 (219-277)* 484 (219-567)*# 403 (219-503)*^ 560 (350-890) 
WORLD SCIENCE                                                                                                                          ISSN 2413-1032 
 
                                                                     № 11(51), Vol.2, November 2019 11 
 
Abbreviations: continuous variables were expressed as median (interquartile range).  
*u<0,05 comparing to the control with Vilkokson-Mann-Witney criterion. 
^ u <0,05 comparing to the patients with LC. 
# u <0,05 comparing to the patients with DLD of moderate and minimal damage.  
In our study correlation analyses demonstrated significant correlation of the data of DC and 
echo (Table 12) and could be the bases for further investigation of diagnostic value of DC in 
evaluation of intracardiac hemodynamic and capillary circulation.  
Table 12. Correlation analyses of the data of DC and echo depending on the etiology of the disease 
Patients with IHD  
n=30 
Patients with IHD and DLD 
n=25 
Patients with DLD  
n=102 
DAC and EFlv (r=0.6; p<0.05). 
LA and FVAC (r=-0.41; p<0.05). 
DVC and Е/А (r=0,42; p<0.05).  
FVVC and Tivs (r=0,47; p<0.05). 
RV and DAC (r=0.39, p<0.05).  
DAC and VCI (r=0.31, p<0.05). 
Abbreviations: r – Pearson’s correlation coefficient. 
Conclusions. So, we revealed in our study that patients with IHD and reduction of contraction 
of LV and its diastolic filling had progressive microcirculatory supply disorder. There was also found 
that concomitant DLD in patients with IHD worsened significantly systolic and diastolic functions of 
LV, aggravated CHI, especially in patients with LC. In our investigation it was proved that presence of 
IHD and DLD caused disorder of cytomicroarchitectonics of the capillaries. We demonstrated value of 
DC in investigation of microcirculatory disorders to detect stages of blood supply disorders and to be 
noninvasive device for monitoring patients with IHD and concomitant DLD. 
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